|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Kidney injury molecule-1outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies显示文摘 | Vaidya V S Ozer J S Dieterle F | 2010 | Nat Biotechnol2010，28，5： | 1 |
| 2 | Central pontine myelinolysis 显示文摘 | Dieterle L Buchler G Pfitzer F | 1992 | Dtsch Med Wochenschr1992，117，9： | 1 |
| 3 | Impact of biomarker development on drug safety assessment 显示文摘 | Marrer E Dieterle F | 2010 | Toxicol Appl Pharmacol2010，243，2： | 1 |
| 4 | Urinary clusterin, cystatin C, β2-microglobulin and total protein as markers to detect drug-induced kidney injury 显示文摘 | Dieterle F Perentes E Cordier A | 2010 | Nat Biotechnol2010，28，5： | 1 |
| 5 | Qualification of biomarkers for regulatory decision making-a kidney safety biomarkers project显示文摘 | Dieterle F Staedtler F Grenet O | 2007 | J Soc Toxicol2007，96，： | 1 |
| 6 | Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preelinieal biomarker qualification studies显示文摘 | VAIDYA V S OZER J S DIETERLE F | 2010 | Nat Biotechnol2010，28，5： | 1 |
| 7 | Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in multi-site preclinical biomarker qualification studies显示文摘 | Vaidya VS Ozer JS Dieterle F | 2010 | Nat Biotechnol2010，28，5： | 1 |
| 8 | Kidney injury molecule-1 out- performs traditional biomarkers of kidney injury in preelinical biomar- ker qualification studies 显示文摘 | Vaidya VS Ozer JS Dieterle F | 2010 | Nat Biotechnol2010，28，5： | 1 |
| 9 | 'Monitoring kidney safety in drug development emerging tech- nologies and their implications' 显示文摘 | Dieterle F Marrer E Suzuki E | 2008 | Curr Opin Drug Discov Devel2008，11，1： | 1 |
| 10 | Live cell imaging reveals actin-cytoskeleton-induced self-association of the actin-bundling protein WLIM1显示文摘 | Hoffmann C Moes D Dieterle M Neumann K Moreau F Tavares F A Dumas D Stein- metz A Thomas C | 2014 | Journal of Cell Science2014，127，3： | 1 |
| 11 | Renal biomar- ker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium 显示文摘 | DIETERLE F SISTARE F GOODSAID F | 2010 | Nat Biotechnol2010，28，5： | 1 |
| 12 | Urinary clusterin, eystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury显示文摘 | Dieterle F Perentes E Cordier A | 2010 | Nat Biotechnol2010，28，5： | 1 |
| 13 | Urinary clusterin,cystatin C, beta2-microglobulin and total protein as markers to detect drug-in- duced kidney injury 显示文摘 | Dieterle F Perentes E Cordier A | 2010 | Nat Biotechnol2010，28，5： | 1 |
| 14 | Uri- nary clusterin, cystatin C, beta2-microglobulin and total protein as markers :o detect drug-induced kidney injury 显示文摘 | Dieterle F Perentes E Cordier A | 2010 | Nat Biotechnol2010，28，5： | 1 |
| 15 | Urinary clusterin,cystatin C,beta2-microglobulin and total protein as markers to detect drug-indueed kidney injury显示文摘 | Dieterle F Perents E Cordier A | 2010 | Nat Bioteehnol2010，28，5： | 1 |
| 16 | Monitoring kidney safety in drug deve-lopment:emerging technologies and their implications显示文摘 | Dieterle F Marrer E Suzuki E | 2008 | Curr Opin Drug Discov Devel2008，11，1： | 1 |
| 17 | Urinary clusterin,cystatin C,β2-microglobulin and total protein as markers to detect drug-induced kidney ingury显示文摘 | Dieterle F Perenes E Cordier A | 2010 | Nat Biotechnol2010，28，5： | 1 |
| 18 | Application of metabonomics in a compound ranking study in early drug development revealing drug-induced excretion of choline into urine 显示文摘 | Dieterle F Schlotterbeck G Ross A | 2006 | Chem Res Toxicol2006，19，9： | 1 |
| 19 | Metabolite projection analysis for fast identification of metabolites in metabonomics: application in an amiodarone study 显示文摘 | Dieterle F Ross A Schlotterbeck G | 2006 | Anal Chem2006，78，11： | 1 |
| 20 | Metabolism of phenylbutazone in man显示文摘 | Dieterle W Faigle JW Fruh F | 1976 | Arzneimittelforschung1976，26，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员